TipHub

₹36.45

■ +0 +0.00%

As of 24 Jul 2026 · delayed

BSE Listed

GSM · GSM 3
What does GSM · GSM 3 mean?
BSE · Graded Surveillance Measure (GSM 3)GSM targets fundamentally weak companies whose price doesn't square with their financials (tiny net worth or negative/extreme P/E). Practical meaning: the exchange doubts the price is backed by the business. Stage 0 is a watchlist; each higher stage makes the stock progressively harder to trade — tighter bands, full upfront margin, weekly-only trading, and at Stage IV no upward price movement at all. Exiting requires a quarterly review finding the criteria no longer met.Criteria: Shortlisted on objective financial parameters — net worth, net fixed assets, price-to-earnings multiple and market capitalisation. Stage 0 = base surveillance watchlist (identified under GSM, no graded price restriction yet); Stages I–VI add escalating curbs (price band, 100% margin, periodic call auction, settlement on a gross/trade-for-trade basis, no upward price movement).Exchange notice · 2026-07-20

Saptak Chem & Business Ltd. (506906)

Volume: 0Avg Vol 1W: 850Avg Vol 1M: 69252W Range:₹6.75₹64.13
BSE www.saptakchem.com AI Report
Key Ratios
Checked just now
Market Cap₹11 Cr
Current Price₹36.45
Previous Close₹36.45
High / Low (52w)₹64.13 / ₹6.75
Volume0
Avg Vol (1W)850
Avg Vol (1M)692
Stock P/E—
Book Value₹-1.49
Dividend Yield0%
ROE20.02%
ROA-26.96%
Revenue (TTM)—
Revenue Growth—
Profit Margin0%
Total Debt—
Shares Outstanding0 Cr
Face Value—
EPS (TTM)₹0
P/B0
Debt / Equity0
50 DMA₹44.01
200 DMA₹37.02
Day change+0.00%
SurveillanceGSM · GSM 3
Price Chart
₹36.45▲ 414.83% · 1Y
₹63₹354K
2025-09-17
2026-07-24

20-day avg volume: 756 shares

Pros
  • Healthy return on equity of 20.0%.
  • Company is almost debt-free.
Cons
  • Company is loss-making at the latest annual result.
  • Negative book value per share.
Quarterly Results
MetricJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
EBITDA₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
Net Profit₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
EPS————————
Profit & Loss (Annual)
MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Revenue₹1 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
EBITDA₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
Net Profit₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
EPS0.10.01-0.01-0.020.010.01-0.03-0.08
Balance Sheet
MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Total Assets₹2 Cr₹2 Cr₹2 Cr₹1 Cr₹2 Cr₹2 Cr₹0 Cr₹0 Cr
Total Liabilities₹4 Cr₹4 Cr₹4 Cr₹4 Cr₹4 Cr₹4 Cr₹2 Cr₹2 Cr
Equity₹-2 Cr₹-2 Cr₹-2 Cr₹-2 Cr₹-2 Cr₹-2 Cr₹-2 Cr₹-2 Cr
Total Debt————————
Cash Flow
MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating₹0 Cr₹0 Cr₹0 Cr₹-1 Cr₹0 Cr
Investing₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
Financing₹0 Cr₹0 Cr₹0 Cr₹1 Cr₹0 Cr
Free Cash Flow₹0 Cr₹0 Cr₹0 Cr₹-1 Cr₹0 Cr
Shareholding
Promoter 4.39% Institutions 0% Public 95.61%
Efficiency & Working Capital
ROCE-26.4%
Interest Coverage0
Dividend Payout—
Debtor Days—
Inventory Days—
Payable Days—
Cash Conversion Cycle—
Working Capital Days—
Shareholding Details

As of 2026-06-30

Promoter4.4%
FII0%
DII0%
Institutions0%
Public95.6%
Promoter Pledge0%
No. of Shareholders2,222
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Promoters16.3%16.3%16.3%16.3%16.3%16.3%16.3%16.3%12.6%12.6%12.6%4.4%
FIIs0%0%0%0%0%0%0%0%0%0%0%0%
DIIs3%3%3%3%3%3%3%3%0%0%0%0%
Public80.7%80.7%80.7%80.7%80.7%80.7%80.7%80.7%87.4%87.4%87.4%95.6%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders10,45210,95210,95210,95210,95212,50112,54612,5202,3902,3902,2182,222
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202503————
Major Shareholders (>1%)
NameCategoryStakeShares
Jayshree JainPublic Shareholding16.3%5,00,000
Hmm Consultancy LlpPublic Shareholding16.3%5,00,000
Akshay Shah HufPublic Shareholding16.3%5,00,000
Ankush Agarwal HufPublic Shareholding16.3%5,00,000
Saptak ChemPublic Shareholding8.4%2,59,001
Alpha Antibiotics LimitedShareholding of Promoter and Promoter Group4.4%1,35,000
Deep Diamond India LimitedPublic Shareholding1.3%40,000
Tvisha Corporate Advisors LlpPublic Shareholding1.3%39,900
Navneet KaurPublic Shareholding1.2%38,025
Munak Engineers Pvt. Ltd.Shareholding of Promoter and Promoter Group0%0
Keshoram Leasing LtdShareholding of Promoter and Promoter Group0%0
Board of Directors
NameDesignationYear
Manthan BhavsarManaging Director2025
Chirag NanavatiIndependent Director2025
Bhoomiben PatelIndependent Director2025
Sonal Deepalbhai GandhiIndependent Director2025
Rohitkumar ParikhManaging Director2025
Krishna Manthan BhavsarCompany Sec. & Compli. Officer2025
Jignesh Keshav BarotAdditional Director2025
Jubin Premji GadaDirector2025
Ajay Suresh YadavDirector2025
Rinku SainiDirector2025
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2025₹10111111
Corporate Actions
TypeDateValueRemark
forthcoming2026-08-01Board Meetings—
Company Information
Incorporated1980
AuditorMeet Shah & Associates/P H Shah & Co
Investor Email[email protected]; [email protected]
🌐 www.saptakchem.com ↗

📍 C-608 Shyam Parisar Nr Dhwani, Heights 8/h Municipal School, Ahmedabad, Gujarat, 382443

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

Tuticorin Alkali Chemicals & Fertilizers Ltd.AstraZeneca PharmaTANFAC Industries Ltd.Gujarat Petrosynthese Ltd.Swadeshi Industries & Leasing Ltd.Master Chemicals Ltd.Makers Laboratories Ltd.Continental Chemicals Ltd.J B Chemicals and PharmaceuticalsIndo Gulf Industries Ltd.Advance Petrochemicals Ltd.Rajasthan Petro Synthetics Ltd.All “50” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search